Results 281 to 290 of about 1,591,431 (356)
Editorial: Advancing livestock health: innovative vaccine strategies to combat antimicrobial resistance. [PDF]
Uddin MB, Hewawaduge C.
europepmc +1 more source
CRISPR/Cas9 has revolutionized the field of gene therapy, but delivery remains an outstanding issue. We propose a nonviral gold‐nanoparticle platform for co‐delivery of CRISPR/Cas9 ribonucleoprotein and long 2.1 kilobase dsDNA transgene constructs. This CRISPR‐AuNP is inexpensive to produce and mediate gene editing and DNA delivery in T cells and CD34+
Rachel A. Cunningham +8 more
wiley +1 more source
A modular strategy was developed to synthesize tri‐, hexa‐, and nona‐saccharides representing repeating units of the conserved O‐polysaccharide backbone of Salmonella. Conjugates of these glycans to bacteriophage Qβ induced strong IgG responses in mice and rabbits. Antibodies elicited recognized native O‐polysaccharides and conferred protection against
Xingling Pan +7 more
wiley +2 more sources
Harnessing conserved epitopes and multivalent antigen strategies for vaccine design: Lessons learned and opportunities. [PDF]
Adjei-Gati E +6 more
europepmc +1 more source
We developed an assay to distinguish cellular binding from internalization. Compatible with microscopy and high‐throughput screening, the method identifies ligand‐mediated uptake. Applying top candidates to a protein‐based DNA carrier enhanced transfection efficiency, providing a rational strategy to improve non‐viral gene delivery systems.
David Scherer +5 more
wiley +1 more source
A Comparative Review of Veterinary and Human Vaccine Development Strategies: Insights into Herpesvirus Vaccinology from Latency to Elimination. [PDF]
Liu G, Zhao X, Lin Y, Wang X, Liu D.
europepmc +1 more source
mRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting. [PDF]
Parganiha M, Rathored J, Sai Painkra D.
europepmc +1 more source
The case for an Epstein-Barr virus vaccine: Lessons from its link to systemic lupus erythematosus. [PDF]
Akingbola A +6 more
europepmc +1 more source
Tracking Canada's 2015 vaccine research and development priorities: Where are we a decade later? [PDF]
Moqueet N +8 more
europepmc +1 more source

